E-commerce stocks are hot right now. As the internet has grown and matured, e-commerce companies have reached the point that many have made traditional retailers obsolete. While traditional retailers suffered financial hardship during the pandemic as their stores operated at reduced capacity, e-commerce companies thrived. Today, the global e-commerce market is estimated at more than
0 Comments
Earlier this month, I discussed how negative sentiment about Plug Power (NASDAQ:PLUG) shares continues to increase. As the hydrogen fuel cell company continues to execute poorly, sell-side analysts continue to grow bearish on PLUG stock. Investors have kept on abandoning it in droves, resulting in PLUG falling back to sub-$10 per share price levels. Shares
0 Comments
To say the market for initial public offerings (IPOs) is in a funk would be a major understatement. In 2022, the worldwide IPO market went from record-breaking levels during the Covid-19 pandemic into a full-on depression, according to an analysis by EY. In 2022, there were 1,333 IPOs held, down 45% from 2021. Proceeds from
0 Comments
Visitors take photos in front of the Meta (Facebook) sign at its headquarters in Menlo Park, California, on December 29, 2022. Tayfun Coskun | Anadolu Agency | Getty Images Check out the companies making headlines in extended trading. Meta Platforms — The Facebook parent popped 9% after announcing better-than-expected top-line results. Meta posted $28.65 billion
0 Comments
At first glance, the first-quarter 2023 results from electric vehicle (EV) manufacturer Tesla (NASDAQ:TSLA) don’t seem all that bad. However, many investors’ initial reaction was to sell TSLA stock. In the wake of this, opinions vary concerning the future trajectory of the Tesla share price. Fortunately, there is a dip-buying strategy that could work well
0 Comments
The other shoe has officially dropped for Bed Bath & Beyond (NASDAQ:BBBY) stock. As you’ve likely heard, the struggling retailer filed for Chapter 11 bankruptcy on April 23. With the market expecting such a development over the past few months, the official news has had less of an impact on the price of BBBY stock
0 Comments
Is Wall Street’s opinion of Plug Power (NASDAQ:PLUG) optimistic or pessimistic? There’s an odd divergence between the ambitious consensus price target on PLUG stock and the multitude of downgrades. Still, hopefully, today we can wade through the sea of opinions and come to a conclusion about Plug Power. Plug Power is probably the most famous publicly
0 Comments
In this article ENPH V GOOGL CMG PACW MSFT Follow your favorite stocksCREATE FREE ACCOUNT 3,760 Enphase microinverters will power the drying and storage of more than 50,000 tons of California rice at Strain Ranch in Arbuckle, Calif., Tuesday, Feb. 19, 2013. Alison Yin | AP Check out the companies making headlines in extended trading.
0 Comments
Sooner or later, investors will stop fearing the “phantom recession,” i.e. the recession that really doesn’t exist except in many economists’ imaginations. At that point, many growth stocks should come soaring back. The latest evidence supporting my “phantom recession” theory came last week, when S&P reported that the U.S. private sector Purchasing Managers’ Index for April came
0 Comments
Loyal investors of electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID) have already been through the wringer. Yet, it’s probably only going to get worse for LCID stock. As we’ll see, May 8 will be an important, and possibly terrible, day for Lucid Group and its stakeholders. Moreover, competition from the likes of Tesla (NASDAQ:TSLA) will only
0 Comments
Source: Robert Way / Shutterstock.com Nio (NYSE:NIO) is facing rapidly increasing competition. Meanwhile, the company’s margins are also being pressured by an accelerating price war in the Chinese electric vehicle (EV) market. But that’s not all. Nio’s addressable market is quite limited and the firm lacks strong competitive advantages. Given all of these points, I
0 Comments
Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body.  It promises to revolutionize healthcare making stocks in companies offering this form of medicine very intriguing.  The potential return on such shares is clearly high: Developing these treatments requires massive investments
0 Comments